马斯克的 Neuralink 计划 2026 年量产脑机接口，同步推出全自动化手术方案 —— 电极丝可直接穿过硬脑膜无需切除，规避传统侵入式设备的创伤问题， 兼顾效率与成本控制。 OpenAI CEO Altman 的 Merge Labs 拆分独立，专攻超声波脑机接口，与马斯克形成对垒，印证技术商业化潜力； 国内格式塔也布局该路线，2026 年脑机 接口将迈入商业化，场景拓展至 AI、机器人领域。 Neuralink 的量产 + 自动化手术，加上 Merge 的超声波脑机布局，有两层意义： 1、脑机接口要从 "医疗试验工具" 变成能普及的产品 —— 相当于从实验室原型机，进到能批量卖的阶段； 2、等技术更成熟，Neuralink 的脑机接口就能和特斯拉 Optimus 人形机器人联动，为后续协同应用打基础。 01 什么是脑机接口 脑机接口（BCI）是大脑与外部设备的直连通信系统，无需手、嘴等常规通路即可互换信息，分三个模块： "脑" 是思维信号的产生源，"机" 是接收信号 执行动作的设备（如电脑、假肢），"接口" 是核心翻译器，负责读写脑信号与转换设备指令，实现想法与设备动作的对应。 脑机接口的关键在 "接 ...

Market Performance - The three major indices collectively rose, with the Shanghai Composite Index increasing by 1.07%, the Shenzhen Component Index by 1.87%, and the ChiNext Index by 2.15% [1] - Over 3,800 stocks in the two markets experienced gains, with a total trading volume of 1.64 trillion [1] Sector Highlights - The brain-computer interface concept surged, with a notable increase of 12.56%, leading to over ten stocks hitting the 20% daily limit up, including Sanbo Brain Science, Botao Biology, Daoshi Technology, and Xiangyu Medical [3] - The commercial aerospace sector remained active, with China Satellite Communications achieving three consecutive trading limits in five days [3] - The insurance sector strengthened, with Xinhua Insurance and China Pacific Insurance both reaching historical highs [3] - The semiconductor industry chain showed robust performance, with stocks like Yaxiang Integration and Shenghui Integration hitting the daily limit up [3] Declining Sectors - The Hainan Free Trade Zone concept faced a decline, dropping by 3.06%, with Hainan Development hitting the daily limit down [3] - Other sectors such as duty-free shops, airports, and tourism hotels followed suit, each experiencing declines of over 1% [3] - The oil, banking, and lottery sectors also faced downward pressure [3] Company News - Salt Lake Co. recently announced its 2025 performance forecast, expecting a net profit attributable to shareholders of 8.29 billion to 8.89 billion, representing a year-on-year growth of 77.78% to 90.65% [3] - In 2025, China has approved 76 innovative drugs for listing, setting a historical record, with total external authorization transaction amounts exceeding 130 billion [3]

Market Overview - The Shanghai Composite Index (SHCI) has strongly reclaimed the 4000-point mark, closing up 1.38% on January 5, 2026, with a total trading volume exceeding 25.67 billion yuan, an increase of 5.02 billion yuan from the previous day [12][29]. - A total of 128 stocks hit the daily limit up, with over 4100 stocks rising across the market [12][29]. Key Sectors - The technology sector, particularly the brain-computer interface (BCI) and domestic chip industries, saw significant gains. Notably, stocks like Sanbo Brain Science and Meihao Medical surged to their daily limits [12][13]. - The BCI sector led the market rally, with nearly 30 stocks within this category hitting the limit up, driven by announcements from Neuralink regarding large-scale production of BCI devices by 2026 [12][13]. - The domestic chip sector also performed well, with storage chips leading the charge. Longxin's prospectus indicated expected revenues of 55-58 billion yuan for 2025, with net profits projected between 2-3.5 billion yuan [12][13]. Investment Trends - The market sentiment is buoyed by the anticipated growth in AI applications, the "going out" trend, and policies aimed at reducing internal competition [9]. - Goldman Sachs has recommended a high allocation to A-shares and Hong Kong stocks in 2026, predicting annual growth of 15% to 20% for the Chinese stock market in 2026 and 2027 [9]. Performance Metrics - The SHCI achieved a record of 12 consecutive daily gains from December 17, 2025, to January 5, 2026, marking the longest streak since March 1992 [1][2]. - The market's strong performance is reflected in the significant increase in trading volume and the number of stocks hitting their daily limits, indicating robust investor interest [12][29]. Sector Analysis - The aerospace sector continued its strong momentum, with stocks like Leike Defense achieving multiple consecutive gains, supported by government announcements regarding military advancements [12][13]. - The AI large model sector also saw a rise, with companies like Nansheng Co. and Liou Co. recording consecutive gains, fueled by partnerships and investments in AI technologies [12][13].

元旦假期后的首个交易日，A股市场迎"开门红"，上证指数收复4000点。 1月5日，上证指数高开高走，盘中突破4000点大关，截至收盘，上证指数报4023.42，涨1.38%。Wind 数据显示，A股4180只股票上涨，全市场成交额2.57万亿元，较前一交易日增量5015亿元。 "2026年的行情有望延续自2024年9月份开启的这轮慢牛、长牛行情。"前海开源基金首席经济学家、基 金经理杨德龙指出，2025年大盘一度站上4000点，确立了这轮牛市的走势，在四季度出现了一定回调， 而在元旦之前市场走出11连阳，重新开始上攻，节后延续了上攻走势，大盘再次站上4000点关口，并实 现12连阳，牛市氛围愈发浓厚。 三大指数大幅上涨 "科技牛"行情有望延续 1月5日，A股三大指数均高开高走。截至收盘，沪指涨1.38%报4023点，深证成指涨2.24%，创业板指涨 2.85%。板块方面，脑机接口、创新药、保险、存储芯片、AI应用、军工装备、有色金属板块涨幅靠 前。 1月5日，A股三大指数均大幅上涨。Wind数据截图 盘面上，脑机接口板块全线大涨，创新医疗、岩山科技、三博脑科、南京熊猫、塞力医疗、爱朋医疗、 国际医学、伟思医疗 ...

Group 1: Company Overview and Business Focus - The company specializes in brain-machine interface (BMI) technology, focusing on sectors such as healthcare, education, and elderly care [3][4] - The company is leveraging advanced multimodal visual analysis technologies to enhance its BMI capabilities [4] Group 2: Development and Market Strategy - The establishment of the joint venture for the brain-machine company is currently in the registration phase with foreign partners [3] - The company plans to launch a brain-machine prototype in March 2026, with initial marketing efforts aimed at brand promotion [4] - The BMI business will target both existing clients in healthcare and education and new customers in consumer electronics, industrial, and research sectors [5] Group 3: Financial Projections and Commitments - The company has a performance commitment with Longzhiyuan, expecting a net profit of no less than RMB 90 million in 2025 [6] - The revenue impact from the brain-machine business is uncertain, although the company is optimistic about its market potential [4]

Group 1 - The article emphasizes the significance of AI and the new computing power revolution, highlighting a potential 10x market expansion with profits concentrating in specific segments of the supply chain [1] - A forecast suggests that 2026 may mark the year for China's commercial rocket reusable launch, urging attention to core "shovel stocks" and new 3D printing technology routes in commercial aerospace investments [1] - The low-altitude economy in Shanghai is undergoing an upgrade, indicating that the eVTOL (electric Vertical Take-Off and Landing) industry chain is at a critical juncture [1] - Elon Musk has accelerated production in the brain-computer interface industry, signaling a pivotal turning point for this sector [1]

Group 1 - The A-share market experienced a strong opening on the first trading day of 2026, with the Shanghai Composite Index surpassing 4000 points, closing up 1.38% at 4023.42 points [1] - Various sectors such as AI, insurance, and pharmaceuticals showed significant activity, with brain-computer interface stocks seeing a surge, including companies like BeiYikang and Sanbo Brain Science reaching their daily limit [1] - The AI application sector saw a notable explosion in the afternoon, with multiple companies hitting their daily limit, indicating strong investor interest and market momentum [1] Group 2 - Recent positive developments in the AI industry include Neuralink's announcement of large-scale production of brain-computer interface devices in 2026, marking a significant breakthrough in AI's integration with biological intelligence [2] - Domestic company Aowei New Materials launched the world's first "backpack-level" humanoid robot, promoting the development of embodied intelligence at lower costs [2] - The financing of over 50 million yuan by Silicon Valley startup Traini for its AI pet collar project expands the boundaries of AI in vertical consumer scenarios, enhancing the emotional interaction and health management service chain in the pet market [2] Group 3 - There is an increasing expectation for a "spring rally" in 2026, driven by favorable factors such as improved overseas conditions, currency appreciation, and proactive domestic policies [3] - The current A-share market is seen as entering a prelude to the "spring rally," characterized by structural leadership and opportunity rotation, unlike previous broad market rallies [3] - The technology sector is expected to maintain its leading position in the market, supported by high-risk appetite and favorable liquidity conditions [3][4] Group 4 - The current market risk appetite remains high, providing room for high-elasticity technology themes to continue their upward trajectory [4] - Despite the technology sector's overall valuation being relatively high, it has not yet reached a frenzy stage, indicating potential for further growth [4] - The strong performance of the AI sector in the US stock market is providing valuation support for corresponding sectors in the A-share market [4]

Market Overview - The A-share market opened strongly in 2026, with the Shanghai Composite Index surpassing 4000 points, closing up 1.38% [1] - The total trading volume reached 2.57 trillion yuan, an increase of 501.5 billion yuan compared to the previous trading day [1] - The market saw over 4100 stocks rise, indicating broad-based gains across sectors [1] Historical Context - The Shanghai Composite Index achieved a record 12 consecutive daily gains from December 17, 2025, to January 5, 2026, marking the longest streak since 1993 [3] - Previous records included an 11-day streak in 2006 and 2017-2018, while extreme cases like the 99-day streak in 1991-1992 are less relevant due to the smaller market size at that time [3] Sector Performance - The brain-computer interface sector led the market, with over thirty stocks hitting the daily limit up, including Sanbo Brain Science and Meihao Medical [6] - The insurance sector also saw significant gains, with Xinhua Insurance and China Pacific Insurance reaching new historical highs [6] - The commercial aerospace sector remained active, with stocks like Reco Defense and China Satellite Communications showing strong performance [6] - The semiconductor industry showed strength, with stocks such as Yaxin Integration and Shenghui Integration hitting the daily limit up [6] Investment Insights - Analysts suggest focusing on the pressure level around 4034 points for potential breakthroughs, indicating a continuation of the short-term bullish trend [5] - The brain-computer interface sector is expected to benefit from policy support, with the inclusion of high-end medical devices in priority approval lists [8] - The semiconductor market is projected to benefit from ongoing supply shortages and strong demand, with companies like Micron expected to perform well [16] Future Outlook - Goldman Sachs released a report recommending an overweight position in Chinese stocks for 2026, highlighting structural growth in exports and investment rebound supported by policy [18] - The report anticipates a 15% to 20% annual increase in the Chinese stock market for 2026 and 2027, driven by a focus on modernizing the industrial system and enhancing technological self-reliance [18]

Group 1 - The brain-computer interface (BCI) sector in A-shares experienced a strong opening on January 5, with the concept index rising over 13%, making it the strongest sector of the day. Stocks within the sector saw a surge, with companies like Beiyikang hitting a 30% limit up, and others like Sanbo Brain Science and Xiangyu Medical achieving 20% limit up [1] Group 2 - Elon Musk announced a production timeline for brain-computer interface devices from Neuralink, aiming for large-scale production to start in 2026. The innovative surgical process will significantly reduce operation time from 6 hours to under 20 minutes, with 12 patients already implanted with the device, accumulating over 15,000 hours of use [4] Group 3 - The global competition in the brain-computer interface field is intensifying, with the U.S. leading in invasive and semi-invasive technologies, while China is advancing in non-invasive methods. Companies like MergeLabs and Brain Tiger Technology are at the forefront of these developments [5] Group 4 - The brain-computer interface has been included in China's "14th Five-Year Plan" as a key future industry, with goals set for technological breakthroughs by 2027 and industry strength to rank among the world's top by 2030. Policies are facilitating market entry, with companies like Xiangyu Medical targeting over 1,000 hospitals by next year [6] Group 5 - The long-term prospects for the brain-computer interface industry are viewed positively by institutions, with predictions of the global market reaching $12.4 billion by 2034 and $320 billion by 2045. Recent capital inflows into the sector indicate a strong interest in its commercial potential [6]

随着马斯克明确给出脑机接口设备的量产时间表，这一前沿赛道正从实验室的科学探索加速走向商业化落地，行业或将迎来从"医疗试验品"向"大众消费品"跨越 的关键转折点。 2026年A股开盘首日，脑机接口板块表现强势。倍益康30CM涨停，三博脑科、翔宇医疗、美好医疗、爱朋医疗、诚益通、伟思医疗等多股20CM涨停，市场资 金对脑机接口商业化前景展现出极高预期。 | 代码 | 名称 | 现价 | 涨跌幅 ▼ | 涨跌 | 换手率 | | --- | --- | --- | --- | --- | --- | | 688108 | 赛诺医疗 | 23.09 | 20.01% | 3.85 | 14.83% | | 300238 | 元 | 16.62 | 20.00% | 2.77 | 13.53% | | 300753 | 爱朋医疗 | 33.30 | 20.00% | 5.55 | 21.10% | | 301363 | 美好医疗 | 28.86 | 20.00% | 4.81 | 1.93% | | 688626 | 翔宇医疗 | 72.60 | 20.00% | 12.10 | 3.36% | | 300003 | ...